Replies to post #746 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[genisi]

Assuming a six month (Class II) review, launch will be delayed to early 2012. We'll know more on the timeline after PLX will meet with the FDA to discuss the CRL.